Hiran Selvadurai

Dr. Hiran Selvadurai


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JSJAGDEV SINGH
JAGDEV SINGH
AJAdam Jaffe
Adam Jaffe
ASAndré Schultz
André Schultz
HSHiran Selvadurai
Hiran Selvadurai

25 July 2017 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
VSVishal Saddi
Vishal Saddi
SBSean Beggs
Sean Beggs
BBBruce Bennetts
Bruce Bennetts
JHJoanne Harrison
Joanne Harrison
NHNeil Hime
Neil Hime
AJAdam Jaffé
Adam Jaffé
Childhood interstitial lung disease (chILD) represents a rare heterogeneous group of respiratory disorders. In the absence of randomized controlled clinical trials, global collaborations have utilized case series with an aim to standardising approaches to diagnosis and management. Australasian data are lacking. The aim of this study was to calculate prevalence and report the experience of chILD in Australasia over a decade. Paediatric pulmonologists in Australia and New Zealand involved in the care of patients aged 0–18 years with chILD completed a questionnaire on demographics, clinical features and outcomes, over a 10 year period. These data, together with data from the 2 reference genetics laboratories, were used to calculate prevalence. One hundred fifteen cases were identified equating to a period prevalence (range) of 1.5 (0.8–2.1) cases/million for children aged 0–18years. Clinical data were provided on 106 patients: the <2 year group comprised 66 children, median age (range) 0.50 years (0.01–1.92); the ≥2 year group comprised 40 children, median age 8.2 years (2.0–18.0). Management approach was heterogeneous. Overall, 79% of patients had a good clinical outcome. Mortality rate was 7% in the study population. chILD is rare in Australasia. This study demonstrates variation in the investigations and management of chILD cases across Australasia, however the general outcome is favorable. Further international collaboration will help finesse the understanding of these disorders.

AJAnna Janssen
Anna Janssen
MKMelanie Keep
Melanie Keep
HSHiran Selvadurai
Hiran Selvadurai
AKAndrea Kench
Andrea Kench
SHSharon Hunt
Sharon Hunt
TSTim Shaw
Tim Shaw
Patient portals are websites or apps that provide patients with tools to manage healthcare appointments, access their health records, and communicate with clinicians. Patient portals have been demonstrated to be beneficial for improving communication between patients/carers and their healthcare team in a range of health settings. However, there is limited research on the barriers and enablers for implementing patient portals from the perspective of health professionals and healthcare teams, particularly in a paediatric setting. This study aimed to understand healthcare teams’ experiences of using a patient portal and, using the Unified Theory of Acceptance and Use of Technology (UTAUT) framework, explore the barriers and enablers to ongoing use. Participants were 11 health professionals participating in the pilot of a patient portal for patients/carers in paediatric care. Data were collected using semi-structured interviews. Analysis of the interview data identified nine themes about implementing a patient portal in paediatric care, all of which aligned with the four constructs of the UTAUT. This study identified that barriers and enablers of the uptake of a patient portal by health professionals in a paediatric context aligned with the UTAUT framework. Value for the patient, improved workflow, and adequate technical and implementation support were highlighted by participants.

18 April 2012 in Nutrients
Verified
Journal Article
Open access
PDF file
BBBen W. R. Balzer
Ben W. R. Balzer
CGChristie L. Graham
Christie L. Graham
MCMaria E. Craig
Maria E. Craig
HSHiran Selvadurai
Hiran Selvadurai
KDKim C. Donaghue
Kim C. Donaghue
KSKate S. Steinbeck
Kate S. Steinbeck
A systematic review was conducted to assess what is known about the effect of low glycaemic index (GI) diets on glycaemic control, weight and quality of life in youth with cystic fibrosis (CF). Eligibility criteria were systematic reviews, randomised and non-randomised trials of low GI dietary interventions in CF. Outcomes examined were glycaemic control, quality of life, anthropometry and respiratory function. Reference lists were manually searched and experts in the field were consulted. Four studies met the eligibility criteria; two were excluded because they did not include data on any of the outcomes. The remaining two were studies that examined GI secondary to any other intervention: one used GI as a factor in enteral feeds and the other incorporated low GI dietary education into its treatment methodology. There is insufficient evidence to recommend use of low GI diets in CF. Since there is evidence to support use of low GI diets in type 1, type 2 and gestational diabetes, low GI diets should be tested as an intervention for CF. The potential risks and benefits of a low GI diet in CF are discussed.

9 January 2017 in Journal of Abnormal Child Psychology
Verified
Journal Article
Closed access
JDJoanne Dudeney
Joanne Dudeney
LSLouise Sharpe
Louise Sharpe
GSGemma Sicouri
Gemma Sicouri
SLSarah Lorimer
Sarah Lorimer
BDBlake F. Dear
Blake F. Dear
CHCaroline Hunt
Caroline Hunt

30 October 2014 in European Respiratory Journal
Verified
Journal Article
Closed access
AMAnna Middleton
Anna Middleton
PRPaul D Robinson
Paul D Robinson
KMKaren McKay
Karen McKay
AJAdam Jaffe
Adam Jaffe
HSHiran Selvadurai
Hiran Selvadurai